DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts

Stock Performance - DaVita HealthCare (DVA) closed at $152 69, marking a +0 77% increase from the previous day [1] - The stock outperformed the S&P 500's daily loss of 1 11% and the Nasdaq's loss of 1 89% [1] - Over the past month, DVA shares depreciated by 4 13%, outperforming the Medical sector's loss of 6 22% but lagging the S&P 500's loss of 1 7% [1] Earnings and Revenue Expectations - The company is expected to report EPS of$ 2 21, up 18 18% from the prior-year quarter [2] - Revenue is predicted to be $3 25 billion, indicating a 3 47% increase compared to the same quarter of the previous year [2] Analyst Estimates and Revisions - Recent changes to analyst estimates reflect short-term business trends, with positive revisions indicating optimism about the company's outlook [3] - The Zacks Rank system, which considers estimate changes, currently rates DVA as a Zacks Rank 2 (Buy) [5] Valuation Metrics - DaVita HealthCare has a Forward P/E ratio of 13 48, indicating a discount compared to its industry's Forward P/E of 20 18 [5] - The PEG ratio is currently 0 74, lower than the industry average of 1 83, suggesting a favorable valuation relative to earnings growth [6] Industry Overview - The Medical - Outpatient and Home Healthcare industry has a Zacks Industry Rank of 87, placing it in the top 35% of all industries [7] - The top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]